NEW YORK (GenomeWeb) – Genetic testing firm Counsyl today announced it raised $28 million in a Series D financing, and it has launched its BRACA1 and BRCA2 screening service.

The financing was co-led by Rosemont Seneca Technology Partners and Goldman Sachs Asset Management and brings the total amount raised by South San Francisco, Calif.-based Counsyl to $93 million, it said. The company will use the funds for product development.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.